Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of business relating to and revolving around the cannabis industry. It holds an interest in MA & Associates LLC, a testing lab providing laboratory testing of cannabis.

Employees

Sector

Healthcare Facilities & Services

More about the company

Market Closed - OTC Markets 22:12:01 08/12/2023 +04			5-day change	1st Jan Change
0.000100 ^USD	-.--%		+9,900.00%	+9,900.00%

28/10/22	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
10/09/20	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI

Market Cap	1.07M 919K 870K 789K 1.48M 102M 1.49M 10.34M 3.98M 51.85M 4.01M 3.92M 164M	P/E 2016	-0.01x	P/E 2017	-0.03x
Enterprise Value	4.11M 3.54M 3.36M 3.04M 5.71M 393M 5.74M 39.86M 15.33M 200M 15.45M 15.11M 632M	EV / Sales 2016	127x	EV / Sales 2017	-
Free-Float	99.91%	Yield 2016 *	-	Yield 2017	-

28/10/22	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
10/09/20	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI
31/12/17	An undisclosed buyer completed the acquisition of 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO).	CI
30/11/17	An undisclosed buyer entered into an agreement to acquire 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO) for $1.5 million.	CI
16/09/17	Pazoo, Inc. Announces Executive Changes	CI
04/04/17	Pazoo, Inc. cancelled the transaction announced on April 4, 2014	CI
14/07/16	Pazoo, Inc Implements New Validating of Testing	CI
18/06/16	Industrial Hemp and Medical Marijuana Consulting Company Signs Agreement with Pazoo	CI
26/04/16	Pazoo, Inc. will Change its Ticker to PZOO from PZOOD	CI
30/03/16	Pazoo, Inc. will Change its Ticker to PZOO from PZOO.D	CI
15/03/16	Pazoo, Inc. Receives Second Six Figure Loan from Two Individual Investors	CI
09/11/15	Pazoo Begins Generating Consulting Based Revenue with the Signing of Operational Advisory Agreement for Denver Colorado Testing Lab	CI
10/07/15	Pazoo, Inc. Signs Distribution Agreement with Pure Grow Systems, LLC	CI

28/10/22	PAZOO, INC. : Entry into a Material Definitive Agreement (form 8-K)	AQ
07/12/20	PAZOO : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
14/11/18	Pazoo : Posts Conference Call Recording	PR
31/10/18	Pazoo, Inc. : Will Hold Conference Call Thursday November 8, 2018/Pazoo Website Back Up	PR
11/10/18	Pazoo : MA & Associates LLC Accepts First Samples and Begins Testing	PR

Pazoo, Inc. Stock

Stocks

PZOO

US70454Q3048

Healthcare Facilities & Services

Valuation : Pazoo, Inc.

Latest news : Pazoo, Inc.

Press Releases : Pazoo, Inc.

Quotes and Performance

Price Extremes

Managers and Directors : Pazoo, Inc.

Medical & Diagnostic Laboratories

Financials

Company Profile

1 week	+9,900.00%
Current month	+9,900.00%
1 month	+9,900.00%
3 months	+9,900.00%
6 months	+9,900.00%
Current year	+9,900.00%

1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0
10 years	0		0.15

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PAZOO, INC.	-.--%	+9,900.00%	+9,900.00%	-.--%	2.69K
NATERA, INC.	+0.86%	+0.23%	+95.20%	+502.77%	47.41B
LABCORP HOLDINGS INC.	+1.49%	-4.70%	+12.08%	+54.54%	25.27B
SONIC HEALTHCARE LIMITED	-1.91%	-2.76%	-16.08%	-39.47%	6.73B
RADNET, INC.	+1.63%	+2.41%	+2.00%	+169.41%	5.94B
DR. LAL PATHLABS LIMITED	-0.40%	+1.68%	+14.18%	+73.09%	3.34B
GENEDX HOLDINGS CORP.	+1.55%	-0.84%	-31.21%	+1,615.59%	2.54B
FLEURY S.A.	+12.74%	+4.41%	+33.29%	+43.46%	2.24B
NEOGENOMICS, INC.	-1.65%	-0.35%	+117.59%	+26.70%	2.23B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-0.73%	-2.96%	-20.55%	-54.88%	1.76B
Average	+1.36%	-0.17%	+1,010.65%	+239.12%	9.75B
Weighted average by Cap.	+1.04%	-1.05%	+51.20%	+311.58%

	2016	2017
Net sales	30.52K 26.29K 24.89K 22.56K 42.33K 2.92M 42.55K 296K 114K 1.48M 115K 112K 4.69M	-
Net income	-8.8M -7.58M -7.18M -6.5M -12.2M -840M -12.26M -85.22M -32.77M -427M -33.03M -32.31M -1.35B	-3.54M -3.05M -2.89M -2.62M -4.92M -339M -4.94M -34.35M -13.21M -172M -13.31M -13.02M -544M
Net Debt	3.44M 2.97M 2.81M 2.55M 4.78M 329M 4.8M 33.37M 12.83M 167M 12.93M 12.65M 529M	3.05M 2.62M 2.49M 2.25M 4.23M 291M 4.25M 29.52M 11.35M 148M 11.44M 11.19M 468M